Yersinia pestis (Yp) - one of the world’s most deadly human pathogens - is the gram-negative bacterium that causes pneumonic plague. Virulent antibiotic-resistant Yp strains exist and Cold War scientists devised means to effectively aerosolize Yp. These facts raise grave concern that Yp will be exploited as a bioweapon. To counter that possibility, it is essential that we develop a safe and effective pneumonic plague vaccine. Recent studies suggest that the leading vaccine candidate, which primarily stimulates antibody-mediated humoral immunity, may not suffice. T cell-dependent cellular immunity comprises a second means by which vaccines prime long-lived protection against virulent bacterial pathogens. However, a plasmid carried by virulent Yp encodes factors that dampen inflammation and debilitate phagocytes, thereby compromising cellular defense mechanisms. As such, plague vaccine researchers have devoted relatively little attention to cellular immunity. Here we review our recent work demonstrating that the passive transfer of primed T cells can suffice to protect mice against lethal intranasal Yp infection, a model of pneumonic plague. We also demonstrate that key elements of cellular immunity even play critical roles during antibody-mediated defense against plague. We conclude that next-generation plague vaccines should strive to prime both cellular and humoral immunity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alibek, K. (1999) Biohazard. Random House, Inc., New York.
Anderson, G.W., Jr., Heath, D.G., Bolt, C.R., Welkos, S.L. and Friedlander, A.M. (1998) Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58, 793-799.
Brubaker, R.R. (2000) Yersinia pestis and bubonic plague. In The prokaryotes, an evolving electronic resource for the microbiological community. Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.-H., and Stackebrandte, E. (eds.) Springer-Verlag, New York, http://141.150.157.117:8080/prokPUB/chaprender/jsp/showchap.jsp?chapnum=265.
Brubaker, R.R. (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71, 3673-3681.
Cowan, C., Philipovskiy, A.V., Wulff-Strobel, C.R., Ye, Z. and Straley, S.C. (2005) Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect. Immun. 73, 6127-6137.
Croft, M. (1994) Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 6, 431-437.
Friedlander, A.M., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, G.W., Jr., Pitt, M.L., Estep, J. and Davis, K. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21 Suppl 2, S178-181.
Galimand, M., Guiyoule, A., Gerbaud, G., Rasoamanana, B., Chanteau, S., Carniel, E. and Courvalin, P. (1997) Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337, 677-680.
Girard, G. (1963) Immunity in plague. Results of 30 years of work on the “Pasteurella pestis Ev” (Girard and Robic) strain. Biol. Med. (Paris). 52, 631-731.
Green, M., Rogers, D., Russell, P., Stagg, A.J., Bell, D.L., Eley, S.M., Titball, R.W. and Williamson, E.D. (1999) The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23, 107-113.
Heath, D.G., Anderson, G.W., Jr., Mauro, J.M., Welkos, S.L., Andrews, G.P., Adamovicz, J. and Friedlander, A.M. (1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine. 16, 1131-1137.
Heesemann, J., Sing, A. and Trulzsch, K. (2006) Yersinia’s stratagem: targeting innate and adaptive immune defense. Curr. Opin. Microbiol. 9, 55-61.
Igietseme, J.U., Eko, F.O., He, Q. and Black, C.M. (2004) Antibody regulation of T cell im-munity: implications for vaccine strategies against intracellular pathogens. Expert Rev. Vaccines. 3, 23-34.
Jones, S.M., Day, F., Stagg, A.J. and Williamson, E.D. (2000) Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four in-bred strains. Vaccine. 19, 358-366.
Kerschen, E.J., Cohen, D.A., Kaplan, A.M. and Straley, S.C. (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72, 4589-4602.
Lukaszewski, R.A., Kenny, D.J., Taylor, R., Rees, D.G., Hartley, M.G. and Oyston, P.C. (2005) Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macro-phages and neutrophils. Infect. Immun. 73, 7142-7150.
Marketon, M.M., DePaolo, R.W., DeBord, K.L., Jabri, B. and Schneewind, O. (2005) Plague bacteria target immune cells during infection. Science. 309, 1739-1741.
Meyer, K.F. (1970) Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 42, 653-666.
Nakajima, R. and Brubaker, R.R. (1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61, 23-31.
Parent, M.A., Wilhelm, L.B., Kummer, L.W., Szaba, F.M., Mullarky, I.K. and Smiley, S.T. (2006) Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral de-fense against lethal pulmonary Yersinia pestis infection. Infect. Immun. 74, 3381-3386.
Parent, M.A., Berggren, K.N., Kummer, L.W., Wilhelm, L.B., Szaba, F.M., Mullarky, I.K. and Smiley, S.T. (2005) Cell-mediated protection against pulmonary Yersinia pestis infec-tion. Infect. Immun. 73, 7304-7310.
Perry, R.D. and Fetherston, J.D. (1997) Yersinia pestis-etiologic agent of plague. Clin. Micro-biol. Rev. 10, 35-66.
Philipovskiy, A.V. and Smiley, S.T. (2007) Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect. Immun. In press.
Pitt, M.L. (2004) Non-human primates as a model for pneumonic plague. Animals Models and Correlates of Protection for Plague Vaccines Workshop. Gaithersburg, MD, http://www.fda.gov/cber/minutes/plague101304t.pdf.
Pujol, C., Grabenstein, J.P., Perry, R.D. and Bliska, J.B. (2005) Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmen-tation locus. Proc. Natl. Acad. Sci. USA. 102, 12909-12914.
Roggenkamp, A., Geiger, A.M., Leitritz, L., Kessler, A. and Heesemann, J. (1997) Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is de-pendent on polymorphism of V antigen. Infect. Immun. 65, 446-451.
Sebbane, F., Lemaitre, N., Sturdevant, D.E., Rebeil, R., Virtaneva, K., Porcella, S.F. and Hinnebusch, B.J. (2006) Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc. Natl. Acad. Sci. USA. 103, 11766-11771.
Straley, S.C. and Cibull, M.L. (1989) Differential clearance and host-pathogen interactions of YopE- and YopK- YopL- Yersinia pestis in BALB/c mice. Infect. Immun. 57, 1200-1210.
Titball, R.W. and Williamson, E.D. (2004) Yersinia pestis (plague) vaccines. Expert Opin. Biol. Ther. 4, 965-973.
Trulzsch, K., Geginat, G., Sporleder, T., Ruckdeschel, K., Hoffmann, R., Heesemann, J. and Russmann, H. (2005) Yersinia outer protein P inhibits CD8 T cell priming in the mouse in-fection model. J. Immunol. 174, 4244-4251.
Velan, B., Bar-Haim, E., Zauberman, A., Mamroud, E., Shafferman, A. and Cohen, S. (2006) Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect. Immun. 74, 6365-6376.
Viboud, G.I. and Bliska, J.B. (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89.
Weeks, S., Hill, J., Friedlander, A. and Welkos, S. (2002) Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathog. 32, 227-237.
Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (1997) A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and pro-tects immunized animals against pneumonic plague. Vaccine. 15, 1079-1084.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Smiley, S.T. (2007). Cell-Mediated Defense Against Yersinia pestis Infection. In: Perry, R.D., Fetherston, J.D. (eds) The Genus Yersinia. Advances In Experimental Medicine And Biology, vol 603. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72124-8_35
Download citation
DOI: https://doi.org/10.1007/978-0-387-72124-8_35
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72123-1
Online ISBN: 978-0-387-72124-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)